Ligand Pharmaceuticals Inc. (LGND)
NASDAQ · Healthcare
Ligand Pharmaceuticals Inc. Total Liabilities 2009–2025
Ligand Pharmaceuticals Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Ligand Pharmaceuticals Inc. total liabilities as of December 31, 2025: 543.4M, a 388.10% increase year-over-year.
- Ligand Pharmaceuticals Inc. total liabilities for 2025 were 543.4M, a 388.10% increase from 2024.
- Ligand Pharmaceuticals Inc. total liabilities for 2024 were 111.3M, a 29.00% increase from 2023.
- Ligand Pharmaceuticals Inc. total liabilities for 2023 were 86.3M, a 47.75% decrease from 2022.
- Ligand Pharmaceuticals Inc. total liabilities for 2022 were 165.2M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ligand Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $543 |
| 2024 | $111 |
| 2023 | $86 |
| 2022 | $165 |
| 2021 | $476 |
| 2020 | $653 |
| 2019 | $728 |
| 2018 | $700 |
| 2017 | $252 |
| 2016 | $231 |
| 2015 | $226 |
| 2014 | $234 |
| 2013 | $55 |
| 2012 | $78 |
| 2011 | $104 |
Ligand Pharmaceuticals Inc. Total Liabilities — FAQ
Ligand Pharmaceuticals Inc. (LGND) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LGND's total liabilities history?
The chart and table above show Ligand Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.